title: [Griseofulvin in the treatment of herpes zoster].
abstract: The authors applied griseofulvin in 46 patients (28 women and 18 men) aged from 21 to 82 years with various forms of zoster. The locations of lesions was different: concerned very often the face and the thorax, rarely the extremities and sometimes the lesions were generalized. The treatment was started in beginning stadium of disease. The total daily oral dose of Griseofulvin-Forte (Medexport/SU were 500 mg (taken in two doses with 2 tablets a 125 mg). A average time of therapy was 10 days. Subjective troubles, pain and burning regressed rapidly and the regression endured. In author's opinion treatment with griseofulvin is efficacious and secure. The time of therapy is very short. The above mentioned method can be recommended to wide, general use.
authors: Z
authors: Z
authors: Gwieździński
authors: F
authors: F
authors: Protas-Drozd
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use*; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D006118:Griseofulvin
vernacular_title: Gryzeofulwina w leczeniu półpaśca.